Local effects of low dose of PTH 1-34 on experimental periodontitis: pilot study
Article Sidebar
Main Article Content
Abstract
Periodontitis is an inflammatory chronic disease with high prevalence in adults that induces a progressive alveolar bone (AB) loss leading to tooth loss. Experimental periodontitis can be induced in rats by cotton ligature placement (LP) in the gingival sulcus around the molar teeth. The biofilm accumulation and disruption of the gingival epithelium lead to bone resorption. We investigated whether intermittent administration of a low dose of PTH 1-34 may recover the alveolar bone loss in the experimental periodontitis induced in female Wistar rats. Animals were randomly divided in two groups which were subcutaneously injected with: saline solution (CT LP) or 0,2 μg/kg PTH 1-34 (PTH LP) three times per week during 17 days. Unligated rats were taken as healthy controls (CT). Anthropometric, biochemical and histologic analysis of tibia and hemimandible were done.
No differences in serum calcium, phosphorus, CTX, PTHi or subchondral tibia bone volume (BV/TV%) were observed between the three groups. AB BV/TV% was significantly lower in PTH LP than in CT but higher than in CT LP (p<0.05). The highest percentage of AB loss was observed in CT LP. The height of periodontal ligament was lower in PTH LP than in CT (p<0.05) but not significantly higher than CT LP.
The increase in AB loss by experimental periodontitis appears to be corrected by the intermittent administration of low doses of PTH without systemic effect. As the recovery of periodontal tissue was only partial, additional studies should be done.
Article Details
Derechos de autor: Actualizaciones en Osteología es la revista oficial de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM) que posee los derechos de autor de todo el material publicado en dicha revista.
References
Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primer; 2017; 3:17038. https://doi.org/10.1038/nrdp.2017.38
Pardo Romero FF, Hernández LJ. Enfermedad periodontal: enfoques epidemiológicos para su análisis como problema de salud pública. Rev Salud Pública; 2018;20:258-264. https://doi.org/10.15446/rsap.V20n2.64654
Tonetti MS, Sanz M. Implementation of the new classification of periodontal diseases: Decision-making algorithms for clinical practice and education. J Clin Periodontol; 2019; 46:398–405. https://doi.org/10.1111/jcpe.13104
Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J; 2020;2020:2146160. https://doi.org/10.1155/2020/2146160
Wang X, Wang Y, Dai X, et al. Effects of Intermittent Administration of Parathyroid Hormone (1-34) on Bone Differentiation in Stromal Precursor Antigen-1 Positive Human Periodontal Ligament Stem Cells. Stem Cells Int; 2016;2016:4027542. doi: 10.1155/2016/4027542
Stutz C, Batool F, Petit C, et al. Influence of parathyroid hormone on periodontal healing in animal models: A systematic review. Arch Oral Biol; 2020;120:104932. doi: 10.1016/j.archoralbio.2020.104932
Pacifici R. The immune system and bone. Arch Biochem Biophys; 2010;503(1):41-53. doi: 10.1016/j.abb.2010.05.027
Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007;40(6):1434-46. doi: 10.1016/j.bone.2007.03.017
Keller H, Kneissel M. SOST is a target gene for PTH in bone. Bone 2005;37(2):148-58. doi: 10.1016/j.bone.2005.03.018
Osagie-Clouard L, Sanghani A, Coathup M, Briggs T, Bostrom M, Blunn G. Parathyroid hormone 1-34 and skeletal anabolic action: the use of parathyroid hormone in bone formation. Bone Jt Res; 2017; 6:4–21.https://doi.org/10.1302/2046-3758.61.BJR-2016-0085.R1
Hagino H, Okano T, Akhter MP, Enokida M, Teshima R. Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia. J Bone Miner Metab; 2001;19(4):244-50. doi: 10.1007/s007740170027
Iida-Klein A, Zhou H, Lu SS, et al. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res; 2002;17(5):808-16. doi: 10.1359/jbmr.2002.17.5.808
Chen H, Fu T, Ma Y, et al. Intermittent administration of parathyroid hormone ameliorated alveolar bone loss in experimental periodontitis in streptozotocin-induced diabetic rats. Arch Oral Biol; 2017;83:76-84. doi: 10.1016/j.archoralbio.2017.06.033
Barros SP, Silva MA, Somerman MJ, Nociti FH Jr. Parathyroid hormone protects against periodontitis-associated bone loss. J Dent Res; 2003;82(10):791-5. doi: 10.1177/154405910308201006
Caruso A, Amico-Roxas M, Cutuli V, Prato A, Fiore CE, Clementi G. Parathyroid hormone fragment 1-34 inhibits drug-induced inflammation in various experimental models. Eur J Pharmacol; 1991;198(1):85-8. doi: 10.1016/0014-2999(91)90565-8
Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods; 2013;394(1-2):49-54. doi: 10.1016/j.jim.2013.05.002
Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. J Periodontal Res; 2011;46(6):655-62. doi: 10.1111/j.1600-0765.2011.01386.x
Harper KD, Krege JH, Marcus R, Mitlak BH. Osteosarcoma and teriparatide? J Bone Miner Res; 2007;22(2):334. doi: 10.1359/jbmr.061111
National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press (US); 2011.
Pulitano Manisagian GE, Benedí D, Goya JA, Mandalunis PM. Study of epithelial rests of Malassez in an experimental periodontitis model. Acta Odontol Latinoam; 2018;31(3):131-137.
Seijo M, Bonanno MS, Vénica CI, et al. A yoghurt containing galactooligosaccharides and having low-lactose level improves calcium absorption and retention during growth: experimental study. Int J Food Sci Technol; 2021;57:48–56. https://doi.org/10.1111/ijfs.15212
Goya JA, Paez HA, Mandalunis PM. Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats. J Periodontol; 2006;77(1):1-6. doi: 10.1902/jop.2006.77.1.1
Liu J, Cao Z, Li C. Intermittent PTH administration: a novel therapy method for periodontitis-associated alveolar bone loss. Med Hypotheses; 2009;72(3):294-6. doi: 10.1016/j.mehy.2008.10.015
Vasconcelos DF, Marques MR, Benatti BB, Barros SP, Nociti FH Jr, Novaes PD. Intermittent parathyroid hormone administration improves periodontal healing in rats. J Periodontol; 2014;85(5):721-8. doi: 10.1902/jop.2013.130155
Bellido T, Saini V, Pajevic PD. Effects of PTH on osteocyte function. Bone; 2013;54(2):250-7. doi: 10.1016/j.bone.2012.09.016
Marques MR, da Silva MA, Manzi FR, Cesar-Neto JB, Nociti FH Jr, Barros SP. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats. Arch Oral Biol; 2005;50(4):421-9. doi: 10.1016/j.archoralbio.2004.08.014
Kim JH, Kim AR, Choi YH, et al. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis. J Transl Med; 2018;16(1):70. doi: 10.1186/s12967-018-1438-2
Otawa M, Tanoue R, Kido H, Sawa Y, Yamashita J. Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice. J Endod; 2015;41(5):646-51. doi: 10.1016/j.joen.2014.12.008
Zhang W, Wu SZ, Zhou J, et al. Parathyroid hormone-related peptide (1-34) reduces alveolar bone loss in type 1 diabetic rats. Arch Oral Biol; 2017;83:13-19. doi: 10.1016/j.archoralbio.2017.06.013
Ubios A, Costa O, Cabrini R. Early steps in bone resorption in experimental periodontitis: A histomorphometric study. Acta Odont Latinoamer; 1993;17:45–49.
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J; 2008;22(3):659-61. doi: 10.1096/fj.07-9574LSF
Dohke T, Iba K, Hanaka M, Kanaya K, Okazaki S, Yamashita T. Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression. J Bone Miner Metab; 2018;36(5):499-507. doi: 10.1007/s00774-017-0865-0
Borba VZC, Mañas NCP. The use of PTH in the treatment of osteoporosis. Arq Bras
Endocrinol Metabol; 2010;54:213–219.